Inventor

Paul J. Soltys

Inventor
Holmdel, NJ, US

Overview

22→
Patents
1993–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Mprimary
A61MDevices for introducing media into, or onto, the body43%
B01DSeparation24%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry22%
A61KPreparations for medical, dental or toiletry purposes4%
A61JContainers specially adapted for medical or pharmaceutical purposes2%
C12MApparatus for enzymology or microbiology2%
C12YEnzymes2%
PatentTitleYear
10,980,931System, method, and composition for removing uremic toxins in dialysis processes202110,363,352Disposable set and system for dialysis201910,232,103System, method, and composition for removing uremic toxins in dialysis processes201910,179,200Disposable cassette and system for dialysis20199,814,820'Weight-controlled sorbent system for hemodialysis'20179,764,074'Systems and methods for performing dialysis'20179,393,356'Method and composition for removing uremic toxins in dialysis processes'20168,998,839'Systems and methods for performing peritoneal dialysis'20158,597,227'Weight/sensor-controlled sorbent system for hemodialysis'20138,491,517'Method and composition for removing uremic toxins in dialysis processes'20138,357,113'Systems and methods for performing peritoneal dialysis'20138,066,658'Method and composition for removing uremic toxins in dialysis processes'20118,002,726'Method and composition for removing uremic toxins in dialysis processes'20117,955,290'Method and composition for removing uremic toxins in dialysis processes'20117,867,214'Systems and methods for performing peritoneal dialysis'20117,241,272'Method and composition for removing uremic toxins in dialysis processes'20075,871,649'Affinity membrane system and method of using same'19995,868,936'Affinity membrane system and method of using same'19995,510,115'Method and composition for administration of beneficial agent by controlled dissolution'19965,480,552'Method for concentrating a solute with an oscillating filtration device'19965,304,130'Container for the controlled administration of a beneficial agent'19945,200,181'Oral bilirubin therapy'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993Based in Somerville, MA, US· patent location history
1994–2021Patents assigned to BAXTER INT (20)· patent assignee history
1994–2013Based in Lake Zurich, IL, US· patent location history
1996Based in Palatine, IL, US· patent location history
2011–2019Patents assigned to BAXTER HEALTHCARE SA (8)· patent assignee history
2011–2013Patents assigned to KAROOR SUJATHA (4)· patent assignee history
2011–2013Patents assigned to MARTIS LEO (4)· patent assignee history
2011–2021Based in Holmdel, NJ, US· patent location history
2013Patents assigned to BROWN DAVID S (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAXTER INT201994–2021
BAXTER HEALTHCARE SA82011–2019
KAROOR SUJATHA42011–2013
MARTIS LEO42011–2013
BROWN DAVID S22013
Locations
LocationPatentsSpan
Holmdel, New Jersey, US112011–2021
Lake Zurich, Illinois, US91994–2013
Palatine, Illinois, US11996
Somerville, Massachusetts, US11993